M Rudhardt
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Pharmacology 16
- Antibiotics Pharmacokinetics and Efficacy 15
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Hepatotoxicity and Protection 3
-
- Pharmacological Effects and Toxicity Studies 7
- Pharmaceutical studies and practices 2
- Co-authors
- J Fabré (12 shared papers)C Regamey (1 shared paper)J Fabre (9 shared papers)L Balant (6 shared papers)Pierre Dayer (3 shared papers)B Cochet (4 shared papers)Mónica Climente Martí (1 shared paper)Fillastre Jp (1 shared paper)
- Journals
- Chemotherapy (4 papers)Infection (2 papers)Acta Haematologica (1 paper)Kidney International (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- Switzerland
In The Last Decade
M Rudhardt
27 papers receiving 255 citations
Peers
Comparison fields: 5 of 63
- Pharmacology 189
- Applied Microbiology and Biotechnology 17
- Molecular Medicine 41
- Pharmacology 46
- Clinical Biochemistry 31
Countries citing papers authored by M Rudhardt
This map shows the geographic impact of M Rudhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Rudhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Rudhardt more than expected).
Fields of papers citing papers by M Rudhardt
This network shows the impact of papers produced by M Rudhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Rudhardt. The network helps show where M Rudhardt may publish in the future.
Co-authors
The 19 scholars most cited alongside M Rudhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 84 | |
| 2 | Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats. | 1980 | 30 |
| 3 | Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy. | 1972 | 29 |
| 4 | 1975 | 24 | |
| 5 | 1977 | 24 | |
| 6 | Influence of renal insufficiency on the excretion of chloroquine, phenobarbital, phenothiazines and methacycline. | 1967 | 21 |
| 7 | Behaviour of doxycycline in renal insuffciency. | 1969 | 16 |
| 8 | [Pharmacokinetics of a new cephalosporin, cefoperazone]. | 1979 | 14 |
| 9 | 1981 | 13 | |
| 10 | 1981 | 13 | |
| 11 | 1984 | 11 | |
| 12 | 1981 | 9 | |
| 13 | Nephrotoxicity of gentamicin. Action on subcellular organelles and pharmacokinetics in the kidney. | 1978 | 6 |
| 14 | [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure]. | 1981 | 6 |
| 15 | [Behavior of gentamicin in the kidney parenchyma. Studies on rats during and after treatment with therapeutic doses]. | 1978 | 5 |
| 16 | [Pharmacokinetic effect of various antibiotics in the tissues]. | 1977 | 3 |
| 17 | [Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)]. | 1979 | 3 |
| 18 | [Effect of various types of liver diseases on the behavior of cefoperazone]. | 1983 | 3 |
| 19 | 1961 | 3 | |
| 20 | 1979 | 2 |
About M Rudhardt
M Rudhardt is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Clinical Biochemistry, Oncology and Nephrology, having authored 30 papers that have together received 331 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Metabolism and Genetic Disorders (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Chemical Reactions and Isotopes (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Pharmacology (189 citations), Applied Microbiology and Biotechnology (17 citations), Molecular Medicine (41 citations), Pharmacology (46 citations) and Clinical Biochemistry (31 citations). M Rudhardt has collaborated with scholars based in Switzerland. Frequent co-authors include J Fabré, C Regamey, J Fabre, L Balant, Pierre Dayer, B Cochet, Mónica Climente Martí, Fillastre Jp, Renato L. Galeazzi and J Fabre. Their work appears in journals such as Chemotherapy, Infection, Acta Haematologica, Kidney International and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.